| |
| |
|
| Insider
Information: |
Gorlin Steve |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
2,272,172 |
|
|
Indirect Shares
|
6,060,392 |
|
|
| Direct
Value |
$950,631 |
|
|
|
Indirect Value
|
$5,608,009 |
|
|
| Total
Shares |
8,332,564 |
|
|
| Total
Value |
$6,558,639 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
8
|
2
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
8.0
|
-2.0
|
| Percentage
Gain/Loss : |
 73.9%
|
 -154.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Director, 10% Owner |
|
0 |
2005-06-08 |
2,657,317 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
Director |
2013-05-16 |
11,500 |
2013-05-16 |
886,645 |
Premium* |
|
|
Point Therapeutics Inc |
POTP |
Director |
|
0 |
2008-02-12 |
2,271,330 |
Premium* |
|
|
Medovex Corp. |
MDVX |
Director within last 9... |
2017-10-30 |
1,640,704 |
2014-12-18 |
125,000 |
Premium* |
|
|
Ontrak, Inc |
OTRK |
Director |
2015-10-16 |
450,000 |
2018-06-15 |
100,000 |
Premium* |
|
|
ImmunityBio, Inc |
IBRX |
Director |
2019-06-06 |
92,592 |
2018-11-29 |
0 |
Premium* |
|
|
PolarityTE, Inc |
PTE |
Director |
2019-08-06 |
31,018 |
|
0 |
Premium* |
|
|
Biovie Inc. |
BIVI |
Director |
2023-12-01 |
46,358 |
2020-10-15 |
20,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIVI |
Biovie Inc. |
Director |
– • – |
2023-12-01 |
4 |
S |
$1.69 |
$127,899 |
D/D |
(75,680) |
46,358 |
0 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2023-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
46,358 |
122,038 |
0 |
- |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2023-09-05 |
4 |
S |
$3.05 |
$26,108 |
D/D |
(8,560) |
75,680 |
0 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2022-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
34,240 |
84,240 |
0 |
- |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-11-03 |
4 |
B |
$7.95 |
$19,319 |
D/D |
2,430 |
45,100 |
2.39 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-30 |
4 |
B |
$7.97 |
$20,483 |
D/D |
2,570 |
42,670 |
2.39 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-21 |
4 |
B |
$9.19 |
$45,950 |
D/D |
5,000 |
40,100 |
2.39 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-15 |
4 |
B |
$10.18 |
$51,967 |
I/I |
5,100 |
20,100 |
2.1 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-15 |
4 |
B |
$10.01 |
$100,550 |
D/D |
10,000 |
30,100 |
2.39 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-09 |
4 |
B |
$9.61 |
$2,710 |
D/D |
282 |
20,000 |
2.31 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-10-07 |
4 |
B |
$9.42 |
$44,444 |
D/D |
4,718 |
19,718 |
2.39 |
% |
|
| BIVI |
Biovie Inc. |
Director |
– • – |
2020-09-22 |
4 |
B |
$10.00 |
$150,000 |
D/D |
15,000 |
15,000 |
2.39 |
% |
|
| PTE |
PolarityTE, Inc |
Director |
– • – |
2019-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
29,718 |
31,018 |
0 |
- |
|
| PTE |
PolarityTE, Inc |
Director |
– • – |
2019-06-10 |
4 |
S |
$5.94 |
$318,978 |
D/D |
(53,700) |
1,300 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
92,592 |
92,592 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-29 |
4 |
S |
$1.65 |
$228,276 |
I/I |
(138,349) |
0 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-29 |
4 |
S |
$1.70 |
$57,785 |
I/I |
(34,019) |
138,349 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-28 |
4 |
S |
$1.76 |
$30,125 |
I/I |
(17,140) |
172,368 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-27 |
4 |
S |
$1.75 |
$175,200 |
I/I |
(100,000) |
189,508 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-23 |
4 |
S |
$2.01 |
$18,717 |
I/I |
(9,312) |
289,508 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-21 |
4 |
S |
$2.02 |
$46,217 |
I/I |
(22,900) |
298,820 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-14 |
4 |
S |
$2.21 |
$255,718 |
D/D |
(115,930) |
0 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-13 |
4 |
S |
$2.40 |
$79,887 |
D/D |
(33,300) |
115,930 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-11-12 |
4 |
S |
$2.43 |
$114,463 |
D/D |
(47,050) |
149,230 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-08-27 |
4 |
S |
$3.09 |
$56,463 |
D/D |
(18,300) |
196,280 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
